| Range: | 1.35-43.8 | Vol Avg: | 483 | Last Div: | 0 | Changes: | 0 |
| Beta: | 0.56 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Financial Services | IPO: | Mon Mar 24 2014 | Empoloyees: | 1 | ||
| CUSIP: | CIK: | 0001452804 | ISIN: | Country: | US | ||
PKPH 1.55 Stock Price Peak Pharmaceuticals, Inc.
Peak Pharmaceuticals, Inc. operates as a biopharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THCfree, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow